Jiajie Biomedical's consolidated revenue in November was NT$36.3 million, a 9% year-on-year increase.

Chia-Chi Biotech Co., Ltd. (hereinafter referred to as "Chia-Chi Biotech", stock code 4109), a leading brand of turtle nutritional health products under the Taiwan Steel Group, announced today (10th) that its revenue in November was NT$36.3 million, an increase of 9% year-on-year. The cumulative revenue in November was NT$426.74 million, a decrease of 10% year-on-year.

Chiajie Biomedical announced that to welcome the last wave of e-commerce consumption at the end of the year, Chiajie Biomedical's e-commerce platform is launching the "Celebrating Double 12" year-end reward event from now until December 31. During the event, all products in the store will enjoy a super value discount of "10% off the first item and 50% off the second item", and customers will receive shopping credits and sandwich gummies with every order. Furthermore, a single purchase of NT$1,000 or more will receive a free "Fast Slimming Fermented Fruit and Vegetable Ferment x Post-Active Tonic Jelly" to boost metabolism; a purchase of NT$2,000 or more will receive an additional "Healthy Walking Non-Denatured Type II Collagen Capsules" focusing on key skincare; and a purchase of NT$3,000 or more will receive an additional "Radiant Glow Calendula Lutein x Wood Ear Mushroom Fruit Capsules". In addition, a "No-Minimum-Amount Value Add-on" promotion is also being launched, allowing customers to add the above three popular products at a discounted price starting from NT$199 at checkout, satisfying diverse consumer needs. For more details on great deals and product information, please visit the Jiajie Biomedical e-commerce platform at https://www.jiajie-mit.com/ or contact customer service at 0800-530-885.

Chiaje Biomedical's Revenue Summary for November 2025: Unit: NT$1,000, %

year During	2025	2024	Annual growth rate
November	36,295	33,436	8.55
January to November	426,738	474,481	-10.06